Last $3.20 USD
Change Today 0.00 / 0.00%
Volume 1.0M
RIGL On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Ryan D. Maynard

Chief Financial Officer, Principal Accounting Officer and Executive Vice President, Rigel Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

43$1,112,025
As of Fiscal Year 2013

Background*

Mr. Ryan D. Maynard has been the Chief Financial Officer of Rigel Pharmaceuticals Inc. since January 2007 and serves as its Principal Accounting Officer. Mr. Maynard has been Executive Vice President of Rigel Pharmaceuticals, Inc. since June 2010. He served as Acting Chief Financial Officer and Vice President of Finance at Rigel Pharmaceuticals, Inc. since June 2006. He served as Vice President of Finance and Acting Chief Financial Officer of Rigel Pharmaceuticals, Inc. ...

Read Full Background

Corporate Headquarters*

1180 Veterans Boulevard
South San Francisco, California 94080

United States

Phone: 650-624-1100
Fax: 650-624-1101

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BS
Santa Clara University

Other Affiliations*

Annual Compensation*

Salary$441,345
Total Annual Compensation$441,345

Stock Options*

All Other Compensation$780

Total Compensation*

Total Annual Cash Compensation$442,125
Total Short Term Compensation$441,345
Other Long Term Compensation$780
Total Calculated Compensation$1,112,025
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RIGL:US $3.20 USD 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Paolo Pucci Chief Executive Officer and Director
ArQule Inc.
$489.3K
Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma, Inc.
$528.2K
James A. Bianco M.D.Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee
Cell Therapeutics, Inc.
$1.3M
Mark R. Baker J.D.Chief Executive Officer, Director, Member of Science & Technology Committee and Member of Strategy & External Technology Subcommittee
Progenics Pharmaceuticals, Inc.
$672.8K
Myung-Joong Cho Ph.D.Founder, Chief Executive Officer and President
CrystalGenomics, Inc.
--
Compensation as of Fiscal Year 2013.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RIGEL PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.